SEC Form 5 · accession 0001225208-16-026368
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald E Bobo Jr.
Officer — CVP, Heart Valve Therapy
Period of report
Dec 31, 2016
Accepted (ET)
Feb 12, 2016 · 5:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 27, 2015 | G | 7,679 | $0.00 | D | 27,679 | D | |
| Common StockF2,F3 | Jul 27, 2015 | G | 7,679 | $0.00 | A | 15,358 | I | By Trust |
| Common StockF4 | holding | — | — | — | 12,280 | I | 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On December 11, 2015, the common stock of Edwards Lifesciences Corporation split 2-for-1, resulting in the reporting person's ownership of additional shares of common stock and stock options. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- F2This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- F3The Bobo Jr. Family Trust U/A/D 5/17/99.
- F4Shares represented on the most recent statement of the 401(k) Plan Administrator where a unitized accounting procedure is utilized to convert the equities to share equivalents.